EXAS vs QGEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

EXAS

64.7
AI Score
VS
EXAS Wins

QGEN

51.6
AI Score

Investment Advisor Scores

EXAS

65score
Recommendation
BUY

QGEN

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EXAS QGEN Winner
Forward P/E 243.9024 13.2979 QGEN
PEG Ratio -1.07 1.0636 Tie
Revenue Growth 23.1% 1.8% EXAS
Earnings Growth 0.0% -23.8% EXAS
Tradestie Score 64.7/100 51.6/100 EXAS
Profit Margin -6.4% 19.2% QGEN
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD EXAS

Relative Price Performance (Last 90 Days)

EXAS 1M: +1.6% · 3M: +3.2% QGEN 1M: +5.8% · 3M: +19.7%

Current Technical Phase

EXAS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.8% over 20 days), RSI 76

RSI (14): 75.9 · Price: $104.91

QGEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.9% over 20 days), RSI 57

RSI (14): 57.5 · Price: $41.40

Fundamentals Snapshot

Metric EXAS QGEN
Market Cap
Forward P/E 55.8 15.8
Trailing P/E 21.3
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.7% 0.7%
Operating Margin -0.1% 0.2%
EPS -1.10 1.96
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, EXAS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.